ExoAtlet

ExoAtlet is a manufacturer of wearable medical exoskeletons designed for clinical rehabilitation and gait restoration. The company develops powered robotic exoskeletons for patients with spinal cord injuries, multiple sclerosis, cerebral palsy, traumatic brain injury, post-stroke conditions, and those recovering from joint arthroplasty. ExoAtlet's flagship product line includes the ExoAtlet II exoskeleton, engineered to support upright walking and lower-limb weight-bearing therapy. The company operates an ExoRehabilitation program that integrates exoskeleton training with physiotherapy and other rehabilitation modalities to facilitate complete or partial gait restoration and improve patients' social and emotional outcomes. As of the website content, ExoAtlet reports 16 clinical studies, partnerships with 24 clinics, and treatment of over 700 patients. The company is led by CEO and founder Kate Bereziy. ExoAtlet's devices are deployed in clinical settings globally for inpatient and outpatient rehabilitation programs targeting neurological and orthopedic populations requiring assistive mobility restoration.